Amended Complaint Merges Medicis Investors' Claims

By Erin Marie Daly · May 19, 2009, 12:00 AM EDT

A legal battle launched against Medicis Pharmaceutical Corp. last year has expanded with the filing of a consolidated amended complaint, which merges proposed class action claims from a slew of investors...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

In re: Medicis Pharmaceutical Corp. Securities Litigation

Case Number

Court

Arizona

Nature of Suit

Other Statutes: Other Statutory Actions

Date Filed

October 03, 2008

Recent Articles By Erin

May 19, 2011
Genentech Sues Apotex Over Generic Valcyte
May 19, 2011
CORRECTED: Mylan's Inequitable Conduct Claim Axed In Vytorin IP Suit
May 18, 2011
Firms, Experts Allowed To Stay In AndroGel MDL
May 10, 2011
Pharmacies Attack $68B Pfizer-Wyeth Deal In 9th Circ.
May 03, 2011
2nd Circ. Rejects Nurses Review Of Class Cert. Denial
April 27, 2011
Genzyme Sues Over Endo's Bid To Sell Generic Renvela
April 27, 2011
Asahi, Actelion Throw Final Punches In Fasudil IP Row
April 20, 2011
Novartis Targets Teva Over Myfortic Patents
April 13, 2011
HGS Fires Round 2 At Genentech Over Lupus Drug IP
April 13, 2011
MetroPlus, HHC Evade State Claims In OT Action